Bandingkan Harga & Kinerja XL Axiata Tbk. (EXCL) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan XL Axiata Tbk. dan Organon Pharma Indonesia Tbk.: XL Axiata Tbk. diperdagangkan di Rp2.630 (kapitalisasi pasar 49,14 T, volume 24 jam 6,84 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: XL Axiata Tbk. jauh lebih besar — sekitar 470,7× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| EXCL | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 49,14 T | 104,4 M |
Volume | 6,84 jt | — |
Lot | 68,44 rb | — |
Perputaran | 18,12 M | — |
Harga Rata-rata | 2.647,02 | — |
Nilai Transaksi | 18,12 M | — |
Harga Ekuilibrium Indikatif | 2.630 | — |
Volume Ekuilibrium Indikatif | 2,22 rb | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang XL Axiata Tbk.
PT XL Axiata Tbk (the Company) which was previously known as PT Excelcomindo Pratama Tbk, was initially established under the name PT Grahametropolitan Lestari. The Company was established on Oct 6th, 1989.The articles of association have been amended several times, most recently on Aug 2, 2005, concerning among other the change of par value, equity and public offering. The company started its operation since October 1996 and was the 3rd biggest company in Indonesia for the number of customer and income.
Selengkapnya di halaman EXCL →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
